Mirtabene Ratiopharm (Mirtazapine)

Mirtazapine blocks presynaptic α2‑adrenergic receptors, increasing norepinephrine and serotonin release, and antagonises postsynaptic 5‑HT2, 5‑HT3 and histamine H1 receptors. This combined action produces antidepressant and sedative effects without directly inhibiting serotonin reuptake.

The appropriate dose of Mirtabene Ratiopharm is determined by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Safety data for mirtazapine in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any potential risk to the fetus or infant, and decisions should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapine differs from SSRIs and SNRIs by its dual antagonism of α2‑adrenergic and specific serotonin receptors, leading to a distinct side‑effect profile that includes sedation and weight gain. It is often chosen when patients need a sedating effect or have poor appetite.

Store Mirtabene Ratiopharm tablets at ambient temperature, below 25 °C, in the original packaging. Keep the product away from moisture, heat and direct sunlight to maintain stability.

Mirtabene Ratiopharm is taken orally, usually once daily in the evening due to its sedative properties. It should be swallowed whole with water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include the potential for suicidal thoughts or behavior, especially at treatment initiation, agranulocytosis, severe hypersensitivity reactions, and serotonin syndrome when combined with other serotonergic drugs. Prompt medical attention is required if any of these occur.

Mirtabene Ratiopharm should be avoided in patients with known hypersensitivity to mirtazapine or any excipients, those currently on MAO inhibitors, and individuals with severe hepatic impairment unless specifically advised by a physician.